The use of corticosteroids in ophthalmology was first introduced in the 1950s by Gordon and McLean1. Corticosteroids exert their anti-inflammatory effects via the inhibition of arachidonic acid and its eicosanoids (prostacyclins, prostaglandins, thromboxanes and leukotrienes). Topical corticosteroids play a paramount role in the management of a variety of inflammatory ocular conditions including uncomplicated anterior uveitis, control of post-surgical inflammation, prophylaxis and corneal allograft rejection treatment, stromal and endothelial herpes simplex keratitis, as per the Herpetic Eye Disease Study (HEDS), and occasionally aspects of keratoconjunctivitis sicca1.
Sign up to keep reading
Create a free Member account at NZ Optics to read this article and more.
- Read all Member articles
- Full digital magazine archive
- Early access to new articles
